Prednisolone

Category
hormone
Half-Life (t½)
PO: 3h · IV: 3h
Formula
C21H28O5
Molecular Weight
360.45 g/mol
PubChem CID
5755
Aliases
Active form of prednisone

Pharmacological Mechanism

Active glucocorticoid — prednisone is reduced to prednisolone by hepatic 11β-HSD1. Direct prednisolone use bypasses the activation step (preferred in liver dysfunction). ~4× cortisol potency. Same indications + adverse effect profile as prednisone.

Half-Life & Elimination Curve (PO: 3h · IV: 3h)

100%50%25%12.5%0%0h0×t½3h1×t½6h2×t½9h3×t½12h4×t½15h5×t½0×t½ (0h): 100% remaining (~0.242 mg/L)1×t½ (3h): 50% remaining (~0.121 mg/L)2×t½ (6h): 25% remaining (~60.5 µg/L)3×t½ (9h): 12.5% remaining (~30.2 µg/L)4×t½ (12h): 6.3% remaining (~15.1 µg/L)5×t½ (15h): 3.1% remaining (~7.56 µg/L)
Plasma (PO)t½ Decay (3h)Effect Site (ke0)
  • 0×t½0h100% (0.242 mg/L)
  • 1×t½3h50% (0.121 mg/L)
  • 2×t½6h25% (60.5 µg/L)
  • 3×t½9h12.5% (30.2 µg/L)
  • 4×t½12h6.3% (15.1 µg/L)
  • 5×t½15h3.1% (7.56 µg/L)
Elimination t½3h (PO)
Rate Constant (ke)0.231 h⁻¹
Time to Peak (Tmax)1.47h
Est. Peak (Cmax)0.242 mg/L
Clearance (CL)11.6 L/h
97% Washout (5×t½)15h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References